Zivo Bioscience

Zivo Bioscience Current Liabilities

The Current Liabilities of Zivo Bioscience (ZIVO) as of Oct 18, 2026 is 4.21 M USD. In the previous year, Current Liabilities was 3.34 M USD — a change of 25.96% (higher).

Current Liabilities

4.21 MUSD

YoY

25.96%

Last updated:

Current Liabilities of Zivo Bioscience is 2025 4.21 M USD. Current Liabilities of Zivo Bioscience was 2024 3.34 M USD. It decreases by 25.96% higher compared to the previous year.

The Zivo Bioscience Current Liabilities history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Current Liabilities
Date
Current Liabilities
Jan 1, 2018
44.35 M USD
Jan 1, 2019
16.05 M USD
Jan 1, 2020
17.35 M USD
Jan 1, 2021
3.77 M USD
Jan 1, 2022
2.87 M USD
Jan 1, 2023
4.36 M USD
Jan 1, 2024
3.34 M USD
Jan 1, 2025
4.21 M USD
The Zivo Bioscience Current Liabilities history
YEARCurrent LiabilitiesYoY
4.21 MUSD+25.96%
3.34 MUSD-23.31%
4.36 MUSD+51.94%
2.87 MUSD-23.89%
3.77 MUSD-78.28%
17.35 MUSD+8.10%
16.05 MUSD-63.82%
44.35 MUSD+475.21%
7.71 MUSD-63.51%
21.13 MUSD+155.50%
8.27 MUSD-25.51%
11.10 MUSD-11.16%
12.50 MUSD+206.08%
4.08 MUSD+111.52%
1.93 MUSD+101.02%
960,349.00USD-75.57%
3.93 MUSD+389.41%
803,162.00USD-0.70%
808,801.00USD-33.80%
1.22 MUSD-25.96%
1.65 MUSD+25.41%
1.32 MUSD+2,773.99%
45,781.00USD—
0.00USD—
0.00USD-100.00%
1,600.00USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Zivo Bioscience Stock analysis

What does Zivo Bioscience do? Zivo Bioscience Inc., headquartered in Keego Harbor, Michigan, develops and commercializes natural nutritional compounds and bioactive molecules derived from proprietary algal strains. The company focuses on research and development of bioactive ingredients for human and animal dietary supplements, medical foods, and pharmaceutical applications, particularly targeting autoimmune and inflammatory response modulation. With 8 employees, it operates in the Consumer Staples sector, specializing in natural health products and diagnostic testing solutions. Zivo Bioscience is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Zivo Bioscience stock

Current Liabilities of Zivo Bioscience is 4.21 M USD in 2025.

Current Liabilities of Zivo Bioscience changed from 3.34 M USD to 4.21 M USD, representing a 25.96% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Current Liabilities Zivo Bioscience since 2006 – with annual values, charts, and detailed analysis.

Current liabilities are obligations due within one year, including accounts payable, short-term debt, and accrued expenses.

Current Liabilities's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Liabilities's Zivo Bioscience historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Balance Sheet — Zivo Bioscience

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — Zivo Bioscience